Our Unorthodoxy
Structure: With the resources of a VC but just a single LP, we make investing decisions quickly and focus on long-term success, not short-term cashouts.
Investments: Check sizes range from $1 million to $5 million with follow-on investments common.
Expertise: Unlike most VCs, we're not bankers. With strong backgrounds in engineering and marketing, our staff helps portfolio companies with PR and manufacturing, as well as go-to-market modeling for those pre-revenue.
Unorthodox support: We offer space at our Austin headquarters to our companies free of charge. Use our 30,000-square-foot warehouse to store trade show booths, products and sales collateral. Opening an American office? Base your first employees here while finding a permanent home.
FEATURED MEDTECH COMPANY
Improving patient outcomes without open-heart surgery
A progressive form of the condition tricuspid regurgitation is considered among the toughest heart valve conditions to treat. Laplace Interventional is developing a novel solution that does not require open-heart surgery, reducing the possibility of future complications in patients. The company's prosthetic valve can be delivered through a minimally invasive procedure, with a goal of increased life expectancy and improved quality of life.
MEET LAPLACE INTERVENTIONAL →FEATURED MEDTECH COMPANY
Reimagining cardiac image guidance
Powered by AI and robotics, Laza Medical's intelligent imaging system is designed to simplify cardiac procedures and put clinicians in control. Built for structural heart, electrophysiology and diagnostic procedures, Laza's system combines real-time 3D heart modeling, procedural guidance, robotic probe control, and an intuitive interface. Together these technologies are designed to open care to more patients.
MEET LAZA MEDICAL →
BLOG
Contrarian to the core
Not surprisingly, we believe more people should think like us. Read on for our opinions about business and why so many people make needless mistakes. (Spoiler alert: It's typically greed and groupthink.)
Who’s on Board? (Or Saving CEOs from Themselves)
Allowing CEOs on the boards of their companies is not good for business and almost always leads to turmoil, as the OpenAI upheaval proved.
Holy Cow (Or When Quality Is Out of Control)
Recent recalls of generic drugs illustrate the inevitable problems when you manufacture anything without strict oversight, especially in a country like India.
MEDIA
We're loud and proud
We have a lot to say, and people have a lot to say about us.
OUR APPROACH
We invest in startups all around the world, often helping overseas companies open their first American offices. Click below to tell us about your work.
Contact Us →